Nurse Practitioner · Miami, FL
NPI
1457704645
Since 2016
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
8900 N Kendall Dr, Miami Cancer Institute
Miami, FL, 33176
Phone (786) 596-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,615
84 services
Medicare patients, 2024
24
Average age 72
Drug cost, 2024
$1.0M
487 prescriptions
Company payments, 2025
$1,649
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria E Jaurrieta was code 99214 (office e&m - established), 38 times for 20 patients. In total Maria E Jaurrieta billed 84 services in 5 codes, and Medicare paid $6,615.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 38 | 20 | $88.64 | $3,368 |
| 99214 Office E&M - Established | Facility | 21 | 12 | $69.20 | $1,453 |
By year: 2022 $3,295 for 48 services; 2023 $2,221 for 30 services; 2024 $6,615 for 84 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maria E Jaurrieta prescribed most often to Medicare patients was Anastrozole, with 137 prescriptions and refills. In total Maria E Jaurrieta wrote 487 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 137 | 405 | 69 | $2,332 |
| Letrozole Generic | 49 | 134 | 28 | $1,602 |
| Exemestane Generic | 43 | 83 | 19 | $7,543 |
| Ibandronate Sodium Generic | 40 | 113 | 19 | $1,043 |
| Ibrance Palbociclib | 26 | 26 | Under 11 | $402K |
| Tamoxifen Citrate Generic | 21 | 64 | 11 | $592 |
| Gabapentin Generic | 18 | 18 | Under 11 | $124 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 14 | 14 | Under 11 | $161 |
| Nerlynx Neratinib Maleate | 13 | 13 | Under 11 | $257K |
| Alendronate Sodium Generic | 13 | 31 | Under 11 | $127 |
| Eliquis Apixaban | 13 | 13 | Under 11 | $7,687 |
| Enoxaparin Sodium Generic | 12 | 12 | Under 11 | $3,406 |
| Ondansetron Hcl Generic | 11 | 11 | 11 | $142 |
Brand drugs: 85 claims; generic drugs: 402 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria E Jaurrieta $1,649 ($1,649 in general payments such as food, travel and fees) from 12 companies. The largest payer was Stemline Therapeutics Inc. with $660.
| Company | Payments | Amount |
|---|---|---|
| Stemline Therapeutics Inc. | 1 | $660 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $397 |
| Janssen Biotech, Inc. JNJ | 2 | $148 |
| Lilly USA, LLC LLY | 4 | $84.99 |
| Daiichi Sankyo Inc. 4568.T | 3 | $80.9 |
| Pfizer Inc. PFE | 3 | $69.42 |
| Merck Sharp & Dohme LLC MRK | 3 | $62.8 |
| Tempus AI, Inc TEM | 2 | $48.1 |
| Gilead Sciences, Inc. GILD | 1 | $34.24 |
| Blueprint Medicines Corporation SNY | 1 | $25.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.